相关实验视频

Updated: Sep 19, 2025

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

兰巴达的沉默:双击淋巴瘤进化的隐藏复杂性

Galina Shevchenko^1,2, Daniel J Hodson^1,2

¹Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Blood cancer discovery

|June 17, 2025

概括

某些具有双击基因转位的高级B细胞淋巴瘤缺乏B细胞受体表达. 这一特征是由RAG酶驱动的,导致对波拉图祖马布韦多治疗的耐药性.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

高度B细胞淋巴瘤 (HGBL) 是一种侵略性的癌症.
以MYC和BCL2转位为特征的双击淋巴瘤 (DHL) 的预后不好.
B细胞受体 (BCR) 信号通路对于B细胞的发育和功能至关重要.

研究的目的:

调查HGBL与MYC和BCL2转位的特征.
确定B细胞受体表达在这些淋巴瘤中的作用.
探索对治疗耐药性的影响,特别是对波拉图祖马布vedotin.

主要方法:

对一组高等级B细胞淋巴瘤样本的分析.
评估MYC和BCL2转位状态.
对B细胞受体表达水平的评估.
研究RAG酶在MYC转位中的作用.
在相关模型中评估对波拉图祖马布维多丁的反应.

主要成果:

具有MYC和BCL2转位的HGBL的一个显著子集缺乏可检测的B细胞受体表达.
这些BCR阴性细胞中的MYC转位由RAG酶介导.
这种RAG介导的转位是由前体细胞中BCR沉默诱导的.
BCR阴性,RAG介导的MYC转位赋予了对波拉图祖马布维多丁的耐药性.

结论:

存在一种独特的双击淋巴瘤分子亚型,其特点是BCR沉默和RAG介导的MYC转位.
这种亚型本质上对波拉图祖马布维多丁有抗性.
了解这种机制对于开发这些侵袭性淋巴瘤的替代治疗策略至关重要.

更多相关视频

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches

Published on: April 20, 2021

相关概念视频

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Secondary Lymphoid Organs

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...